OPA Bulletin

  • News for the week of November 5, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Updated: Frequently Asked Questions on Improving the Value of Pharmacy Payments

    • FAQs and a New Drugs Update on Contraception and Abortion Care
    • Drugs in Chronic Kidney Disease: Implications for Pharmacists
    • Medical Devices Training for Pharmacy Technicians

    • Ask the Customer Experience and Administration Team

    • How does the OPA PLI Program compare with other policies?

    • DDD Notice No. 19162 posted November 4, 2019 Prescription Forgery Alert
    • DDD Notice No. 19161 posted November 4, 2019 Prescription Forgery Alert

  • News for the week of October 29, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Towards a sustainable Ontario Drug Benefit Program
    • OPA submission on OCP expanded scope of practice consultation

    • Identifying Drug Interactions
    • Pharmacist Health Coaching – Cardiovascular Program Training Course
    • Interprofessional Relationships and Conflict Management in Primary Care

    • Ask the Practice Support Network
    • Flash Sale: Save 30% Off Dell XPS and Alienware

    • Universal Influenza Immunization Program and Store Insurance
    • Last chance to win a tablet

    • DDD Notice No. 19160 posted October 29, 2019 Prescription Forgery Alert
    • DDD Notice No. 19159 Posted October 29, 2019 Health Network System (HNS) And Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
    • DDD Notice No. 19158 posted October 29, 2019 Prescription Forgery Alert
    • DDD Notice No. 19157 posted October 28, 2019 Notice: Proposal to Reduce Administrative Burden to Drug Manufacturers and Pharmacies
    • DDD Notice No. 19156 posted October 28, 2019 Notice: Proposal to Improve the Value of Pharmacy Payments
    • DDD Notice No. 19155 posted October 24, 2019 ODB Formulary – Edition No. 43, Summary of Changes – October 2019
    • DDD Notice No. 19154 posted October 23, 2019 Prescription Forgery Alert

    • Drug Shortage / Supply Health System Alert: Tamoxifen

  • News for the week of October 22, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: 2019-20 Universal Influenza Immunization Program (UIIP) Updates
    • Last week to submit feedback on proposed amendments to expand the scope of practice for pharmacists
    • OPA's Student Advisory Council gets underway
    • McMaster University survey on cannabis

    • FREE - Assessment and Management of Patients with Migraine
    • FREE - Introduction to Caring for Trans Patients in the Pharmacy
    • Selling What You Can Do for Your Clients Program

    • Ask the Customer Experience and Administration Team
    • Spooky Halloween party at Ripley's Aquarium of Canada

    • Store Insurance Risk Prevention
    • Last chance to win a tablet

    • DDD Notice No. 19152 posted October 17, 2019 Prescription Forgery Alert
    • DDD Notice No. 19151 posted October 16, 2019 Notice: Pharmacist administration of publicly funded influenza vaccines and claims submission using the Health Network System

    • Additional ranitidine products recalled, including Zantac; request to stop distribution remains in place while Health Canada continues to assess NDMA

  • News for the week of October 15, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Today was Pharmacy Technician Day!
    • OPP reminder regarding prescription forgeries
    • OPA Student Chapter Executive Teams announced
    • U of T Pharmacy Undergraduate Awards
    • U of T 8T9 Class Reunion

    • Personal Branding for Pharmacy Professionals
    • FREE! An Introduction to Caring for Trans Patients in the Pharmacy
    • An Update on Direct Oral Anticoagulation

    • Ask the Practice Support Network

    • Must-have insurance
    • Win a tablet with the best-in-class coverage

    • Drug Shortage / Supply Health System Alert: SOGC Statement - Oxytocin

    • Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove from their carrier tubes
    • Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring
    • LEMTRADA® (alemtuzumab) – Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions - sanofi-aventis Canada Inc.

  • News for the week of October 8, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Reminder to complete our survey on the first three initiatives to expand scope of practices for pharmacists
    • Federal campaign resources from our pharmacy partners

    • Paid Consultations - Opportunities and Timesavers
    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • Injections and Immunizations Program

    • Ask the Customer Experience and Administration Team

    • Surviving a critical illness
    • Win a tablet with the best-in-class coverage

    • Drug Shortage / Supply Health System Alert: Multiple Oncology Products (Fludarabine, Hydroxyurea, Raltitrexed, Tamoxifen)
    • Drug Shortage / Supply Health System Alert: Pfizer Canada - Oxytocin 1ml ampoule

    • DDD Notice No. 19147 posted October 4, 2019 Prescription Forgery Alert
    • DDD Notice No. 19148 posted October 4, 2019 Prescription Forgery Alert

  • News for the week of October 1, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Complete our survey on the first three initiatives to expand scope of practices for pharmacists

    • Opioid Addictions and Substitution Therapy FREE Online Modules
    • The Master Plan for Diabetes Continuing Education Program
    • Identifying Drug Interactions

    • Ask the Practice Support Network

    • OPA Secure Health Plan: All-in-one health care package
    • Win a tablet with the best-in-class coverage

    • Drug Shortage / Supply Health System Alert: Fresenius Kabi - Oxytocin 1ml vial

    • DDD Notice No. 19141 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19140 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19139 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19138 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19137 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19136 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19135 posted September 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19134 posted September 30, 2019 Notice from the Executive Office

    • Ranitidine - Information Update
    • Health Product InfoWatch - September 2019

  • News for the week of September 24, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Fluzone® High-Dose not made available in pharmacy this flu season
    • September 25, 2019 is World Pharmacists Day!

    • Take-Home Naloxone Program at Community Pharmacies
    • Opioid Addiction and Substitution Therapy Free Live Webinar Series
    • Medical Devices Training for Pharmacy Technicians

    • Ask the Customer Experience and Administration Team
    • Don't miss out! TELUS bonus offer ends September 30, 2019

    • Protect your vehicle and home with the right insurance coverage

    • DDD Notice No. 19133 posted September 20, 2019 ODB Formulary – Edition No. 43, Summary of Changes – September 2019 Summary of Product Changes

    • Gripe Water - Information Update
    • Abbott brand Calcilo XD Powder recalled due to rancidity and off-colour

  • News for the week of September 17, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • September 17, 2019 is declared the first World Patient Safety Day
    • Your fall issue of Ontario Pharmacist and Ontario Pharmacy Technician magazines are here!

    • Injections and Immunizations Program
    • How-To: Ontario's Pharmaceutical Opinion Program
    • Identifying Drug Interactions

    • Ask the Practice Support Network
    • A new focus on students: an engagement strategy
    • Take the 2019-20 OPA membership survey

    • Professional liability coverage - practising in another province

    • Pfizer Canada supply update on PrZINECARD®

    • DDD Notice No. 19130 posted September 13, 2019 Notice from the Executive Officer
    • DDD Notice No. 19127 posted September 12, 2019 Notice from the Executive Officer: Funding Flash Glucose Monitoring System Through the Ontario Drug Benefit Program

    • Gabapentin or Pregabalin with Opioids - Information Update
    • Health Canada requests that companies stop distributing ranitidine drugs in Canada while it assesses NDMA; some products being recalled
    • Needle-free dermal filler devices - Information Update

  • News for the week of September 10, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • FluMist Quadrivalent not available this year
    • International Federation on Ageing unites groups to improve vaccination rates
    • Innovative Medicines Canada announces changes to Code of Ethical Practices
    • Political parties gear up for federal election

    • FREE! An Introduction to Caring for Trans Patients in the Pharmacy
    • Implementing Smoking Cessation Services in the Pharmacy
    • Injections and Immunizations Program

    • Ask the Customer Experience and Administration Team
    • Travel discounts as an associate member of CPhA

    • Why buy life insurance?

    • Drug Shortage / Supply Health System Alert: multiple cancer drugs

    • Notice No. 19125 posted September 10, 2019 Prescription Forgery Alert

  • News for the week of September 3, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Justin J. Bates begins new tenure at OPA as new CEO
    • Materials to help in the fight against the opioid crisis

    • OPA Pharmacy Technician Bundle
    • OPA Clinical Bundle
    • OPA Operational Bundle

    • Are you taking advantage of your membership benefits?

    • Overage dependent coverage

    • Health Product InfoWatch - Safety Updates: Cymbalta, Istodax

Back to top